Nuclera Appoints Carl Raimond as Chief Executive Officer
- Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific
- Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business Officer
